[Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].

Hattori, H; Mikuriya, S; Mamiya, T; Hatano, K; Shiina, T; Yamada, T

Hattori, H; Mikuriya, S; Mamiya, T; Hatano, K; Shiina, T; Yamada, T.

Affiliation

Hattori H; Dept. of Radiology, National Medical Center Hospital.

Gan No Rinsho ; 34(7): 851-6, 1988 Jun.

Article in Ja | MEDLINE | ID: mdl-3135423

Subject(s)

Adjuvants, Immunologic/administration & dosage; Biological Products/administration & dosage; Doxorubicin/administration & dosage; Mitomycins/administration & dosage; Neoplasms/complications; Picibanil/administration & dosage; Pleurisy/drug therapy; Adjuvants, Immunologic/therapeutic use; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Doxorubicin/therapeutic use; Female; Fever/chemically induced; Humans; Injections/methods; Leukopenia/chemically induced; Mitomycin; Mitomycins/therapeutic use; Picibanil/therapeutic use; Pleurisy/etiology; Prognosis; Thorax

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Picibanil / Pleurisy / Biological Products / Doxorubicin / Adjuvants, Immunologic / Mitomycins / Neoplasms Type of study: Etiology_studies / Prognostic_studies Limits: Aged / Female / Humans Language: Ja Journal: Gan No Rinsho Year: 1988 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links